Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 154

Similar articles for PubMed (Select 23169331)

1.

Frequency of stavudine substitution due to toxicity in children receiving antiretroviral treatment in sub-Saharan Africa.

Palmer M, Chersich M, Moultrie H, Kuhn L, Fairlie L, Meyers T.

AIDS. 2013 Mar 13;27(5):781-5. doi: 10.1097/QAD.0b013e32835c54b8.

PMID:
23169331
2.

Evaluating adverse drug reactions among HAART patients in a resource-constrained province of South Africa.

Manickum VK, Suleman F.

Afr J AIDS Res. 2012 Jun;11(2):75-81. doi: 10.2989/16085906.2012.698050.

PMID:
25859910
3.

An assessment of adverse drug reactions among HIV positive patients receiving antiretroviral treatment in South Africa.

Masenyetse LJ, Manda SO, Mwambi HG.

AIDS Res Ther. 2015 Mar 5;12:6. doi: 10.1186/s12981-015-0044-0. eCollection 2015.

4.

Durability of first antiretroviral treatment in HIV chronically infected patients: why change and what are the outcomes?

Moniz P, Alçada F, Peres S, Borges F, Baptista T, Miranda AC, Antunes I, Aldir I, Ventura F, Nina J, Mansinho K.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19797. doi: 10.7448/IAS.17.4.19797. eCollection 2014.

5.

Lamivudine monotherapy as a safe option for HIV-infected paediatric clients with adherence challenges: new evidence from a large South African cohort.

Linder V, Goldswain C, Boon G, Carty C, Jackson V, Harper K, Lambert J.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19763. doi: 10.7448/IAS.17.4.19763. eCollection 2014.

6.

Estimation of the true incidence of lactic acidosis within the Lighthouse Clinic cohort, and the likely magnitude of missed diagnoses in the region.

Speight C, Gabriel L, Phiri S, Tweya H, Sutherland R.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19558. doi: 10.7448/IAS.17.4.19558. eCollection 2014.

7.

Incidence and predictors of regimen-modification from first-line antiretroviral therapy in Thailand: a cohort study.

Tsuchiya N, Pathipvanich P, Wichukchinda N, Rojanawiwat A, Auwanit W, Ariyoshi K, Sawanpanyalert P.

BMC Infect Dis. 2014 Oct 30;14:565. doi: 10.1186/s12879-014-0565-5.

8.

The challenge of paediatric efavirenz dosing: implications and way forward for the sub-Saharan Africa.

Mukonzo JK.

AIDS. 2014 Aug 24;28(13):1855-7. doi: 10.1097/QAD.0000000000000372. No abstract available.

PMID:
25259700
9.
10.

Trends in first-line antiretroviral therapy in Asia: results from the TREAT Asia HIV observational database.

Boettiger DC, Kerr S, Ditangco R, Merati TP, Pham TT, Chaiwarith R, Kiertiburanakul S, Li CK, Kumarasamy N, Vonthanak S, Lee C, Van Kinh N, Pujari S, Wong WW, Kamarulzaman A, Zhang F, Yunihastuti E, Choi JY, Oka S, Ng OT, Kantipong P, Mustafa M, Ratanasuwan W, Sohn A, Law M.

PLoS One. 2014 Sep 3;9(9):e106525. doi: 10.1371/journal.pone.0106525. eCollection 2014.

11.

HIV Associated Sensory Neuropathy.

G A, S PK, B N, Bs N.

J Clin Diagn Res. 2014 Jul;8(7):MC04-7. doi: 10.7860/JCDR/2014/8143.4531. Epub 2014 Jul 20.

12.

[Pharmacosurveillance regarding Colombian patients being treated with stavudine].

Machado-Alba JE.

Rev Salud Publica (Bogota). 2013 May-Jun;15(3):446-54. Spanish.

13.

Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.

Bwakura-Dangarembizi M, Musiime V, Szubert AJ, Prendergast AJ, Gomo ZA, Thomason MJ, Musarurwa C, Mugyenyi P, Nahirya P, Kekitiinwa A, Gibb DM, Walker AS, Nathoo K; ARROW Trial Team.

Pediatr Infect Dis J. 2015 Feb;34(2):e23-31. doi: 10.1097/INF.0000000000000491.

14.

Peripheral neuropathy in children on stauvudine therapy.

Sankhyan N, Lodha R, Sharma S, Menon PR, Choudhary A, Kabra SK, Gulati S.

Indian J Pediatr. 2015 Feb;82(2):136-9. doi: 10.1007/s12098-014-1477-5. Epub 2014 May 31.

PMID:
24874810
15.

High-level cross-resistance to didanosine observed in South African children failing an abacavir- or stavudine-based 1st-line regimen.

Steegen K, Levin L, Ketseoglou I, Bronze M, Papathanasopoulos MA, Carmona S, Stevens W.

PLoS One. 2014 May 9;9(5):e97067. doi: 10.1371/journal.pone.0097067. eCollection 2014.

16.

Availability of data on adverse reactions to antiretroviral drugs in medical charts according to the Naranjo algorithm: an example of a Brazilian historical cohort.

Menezes de Pádua CA, Moura CS.

Clin Drug Investig. 2014 Jun;34(6):395-402. doi: 10.1007/s40261-014-0187-0.

PMID:
24710738
17.

Clinical assessment of peripheral neuropathy in HIV-infected children on antiretroviral therapy in rural South Africa.

Peters RP, Van Ramshorst MS, Struthers HE, McIntyre JA.

Eur J Pediatr. 2014 Sep;173(9):1245-8. doi: 10.1007/s00431-014-2303-9. Epub 2014 Apr 2.

PMID:
24691679
18.

[Prevalence of metabolic complications after 10 years of antiretroviral treatment in Senegal].

Diouf A, Cournil A; groupe d’étude de la Cohorte ANRS 1215.

Bull Soc Pathol Exot. 2014 Oct;107(4):234-7. doi: 10.1007/s13149-014-0349-6. Epub 2014 Mar 28. French.

PMID:
24683016
19.

Influence of adverse drug reactions on treatment success: prospective cohort analysis of HIV-infected individuals initiating first-line antiretroviral therapy in India.

Shet A, Antony J, Arumugam K, Kumar Dodderi S, Rodrigues R, DeCosta A.

PLoS One. 2014 Mar 10;9(3):e91028. doi: 10.1371/journal.pone.0091028. eCollection 2014.

20.

A prospective study of haematological changes after switching from stavudine to zidovudine-based antiretroviral treatment in HIV-infected children.

Singh A, Hemal A, Agarwal S, Dubey N, Buxi G.

Int J STD AIDS. 2014 Feb 10. [Epub ahead of print]

PMID:
24516076
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk